| Year |
Citation |
Score |
| 2020 |
Goodman AM, Allendorfer JB, Blum AS, Bolding MS, Correia S, Ver Hoef LW, Gaston TE, Grayson LE, Kraguljac NV, Lahti AC, Martin AN, Monroe WS, Philip NS, Tocco K, Vogel V, et al. White matter and neurite morphology differ in psychogenic nonepileptic seizures. Annals of Clinical and Translational Neurology. PMID 32991786 DOI: 10.1002/acn3.51198 |
0.464 |
|
| 2020 |
Rich M, Whitsitt Q, Lubin F, Bolding M. A Benchtop Approach to the Location Specific Blood Brain Barrier Opening using Focused Ultrasound in a Rat Model. Journal of Visualized Experiments : Jove. PMID 32597853 DOI: 10.3791/61113 |
0.546 |
|
| 2020 |
Rich MC, Sherwood J, Bartley AF, Whitsitt QA, Lee M, Willoughby WR, Dobrunz LE, Bao Y, Lubin FD, Bolding M. Focused ultrasound blood brain barrier opening mediated delivery of MRI-visible albumin nanoclusters to the rat brain for localized drug delivery with temporal control. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 32376461 DOI: 10.1016/J.Jconrel.2020.04.054 |
0.57 |
|
| 2017 |
Sherwood J, Rich M, Lovas K, Warram J, Bolding MS, Bao Y. T1-Enhanced MRI-visible nanoclusters for imaging-guided drug delivery. Nanoscale. PMID 28786462 DOI: 10.1039/C7Nr04181K |
0.302 |
|
| 2017 |
Kim H, Mousa M, Schexnailder P, Hergenrother R, Bolding M, Ntsikoussalabongui B, Thomas V, Morgan DE. Portable perfusion phantom for quantitative DCE-MRI of the abdomen. Medical Physics. PMID 28692137 DOI: 10.1002/Mp.12466 |
0.394 |
|
| 2016 |
Sherwood J, Lovas K, Rich M, Yin Q, Lackey K, Bolding MS, Bao Y. Shape-dependent cellular behaviors and relaxivity of iron oxide-based T1 MRI contrast agents. Nanoscale. PMID 27714177 DOI: 10.1039/C6Nr06158C |
0.316 |
|
| 2016 |
Kraguljac NV, Frölich MA, Tran S, White DM, Nichols N, Barton-McArdle A, Reid MA, Bolding MS, Lahti AC. Ketamine modulates hippocampal neurochemistry and functional connectivity: a combined magnetic resonance spectroscopy and resting-state fMRI study in healthy volunteers. Molecular Psychiatry. PMID 27480494 DOI: 10.1038/Mp.2016.122 |
0.737 |
|
| 2015 |
Ward MK, Bolding MS, Schultz KP, Gamlin PD. Mapping the macaque superior temporal sulcus: functional delineation of vergence and version eye-movement-related activity. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 35: 7428-42. PMID 25972171 DOI: 10.1523/Jneurosci.4203-14.2015 |
0.723 |
|
| 2015 |
Bag AK, Kim H, Gao Y, Bolding M, Warren PP, Fathallah-Shaykh HM, Gurler D, Markert JM, Fiveash J, Beasley TM, Khawaja A, Friedman GK, Chapman PR, Nabors LB, Han X. Prolonged treatment with bevacizumab is associated with brain atrophy: a pilot study in patients with high-grade gliomas. Journal of Neuro-Oncology. 122: 585-93. PMID 25711673 DOI: 10.1007/S11060-015-1751-Z |
0.748 |
|
| 2014 |
Bolding MS, Lahti AC, White D, Moore C, Gurler D, Gawne TJ, Gamlin PD. Vergence eye movements in patients with schizophrenia. Vision Research. 102: 64-70. PMID 25088242 DOI: 10.1016/J.Visres.2014.07.008 |
0.729 |
|
| 2014 |
Hutcheson NL, Clark DG, Bolding MS, White DM, Lahti AC. Basal ganglia volume in unmedicated patients with schizophrenia is associated with treatment response to antipsychotic medication. Psychiatry Research. 221: 6-12. PMID 24210948 DOI: 10.1016/J.Pscychresns.2013.10.002 |
0.751 |
|
| 2014 |
Hadley JA, Nenert R, Kraguljac NV, Bolding MS, White DM, Skidmore FM, Visscher KM, Lahti AC. Ventral tegmental area/midbrain functional connectivity and response to antipsychotic medication in schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 1020-30. PMID 24165885 DOI: 10.1038/Npp.2013.305 |
0.728 |
|
| 2014 |
Macher T, Totenhagen J, Sherwood J, Qin Y, Gurler D, Bolding MS, Bao Y. Ultrathin iron oxide nanowhiskers as positive contrast agents for magnetic resonance imaging Advanced Functional Materials. 25: 490-494. DOI: 10.1002/Adfm.201403436 |
0.757 |
|
| 2013 |
Bolding MS, Reid MA, Avsar KB, Roberts RC, Gamlin PD, Gawne TJ, White DM, den Hollander JA, Lahti AC. Magnetic transfer contrast accurately localizes substantia nigra confirmed by histology. Biological Psychiatry. 73: 289-94. PMID 22981657 DOI: 10.1016/J.Biopsych.2012.07.035 |
0.73 |
|
| 2012 |
Bolding MS, White DM, Hadley JA, Weiler M, Holcomb HH, Lahti AC. Antipsychotic Drugs Alter Functional Connectivity between the Medial Frontal Cortex, Hippocampus, and Nucleus Accumbens as Measured by H215O PET. Frontiers in Psychiatry. 3: 105. PMID 23230425 DOI: 10.3389/Fpsyt.2012.00105 |
0.717 |
|
| 2012 |
Bolding MS, Lahti AC, Gawne TJ, Hopkins KB, Gurler D, Gamlin PD. Ocular convergence deficits in schizophrenia. Frontiers in Psychiatry. 3: 86. PMID 23087652 DOI: 10.3389/Fpsyt.2012.00086 |
0.723 |
|
| 2012 |
Hutcheson NL, Reid MA, White DM, Kraguljac NV, Avsar KB, Bolding MS, Knowlton RC, den Hollander JA, Lahti AC. Multimodal analysis of the hippocampus in schizophrenia using proton magnetic resonance spectroscopy and functional magnetic resonance imaging. Schizophrenia Research. 140: 136-42. PMID 22831772 DOI: 10.1016/J.Schres.2012.06.039 |
0.727 |
|
| 2011 |
Avsar KB, Stoeckel LE, Bolding MS, White DM, Tagamets MA, Holcomb HH, Lahti AC. Aberrant visual circuitry associated with normal spatial match-to-sample accuracy in schizophrenia. Psychiatry Research. 193: 138-43. PMID 21782395 DOI: 10.1016/J.Pscychresns.2011.03.008 |
0.77 |
|
| 2010 |
Reid MA, Stoeckel LE, White DM, Avsar KB, Bolding MS, Akella NS, Knowlton RC, den Hollander JA, Lahti AC. Assessments of function and biochemistry of the anterior cingulate cortex in schizophrenia. Biological Psychiatry. 68: 625-33. PMID 20570244 DOI: 10.1016/J.Biopsych.2010.04.013 |
0.78 |
|
| 2010 |
Gamlin P, Ward M, Likova L, Bolding M, Tyler C. Cortical regions for the processing of stereoscopic motion in depth as revealed by fMRI in the alert rhesus monkey Journal of Vision. 9: 684-684. DOI: 10.1167/9.8.684 |
0.742 |
|
| 2006 |
Gamlin PD, Ward MK, Bolding MS, Grossmann JK, Twieg DB. Developing functional magnetic resonance imaging techniques for alert macaque monkeys. Methods (San Diego, Calif.). 38: 210-20. PMID 16481198 DOI: 10.1016/J.Ymeth.2005.08.004 |
0.763 |
|
| Show low-probability matches. |
